Reference health

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression

https://doi.org/10.1136/annrheumdis-2021-220626
CiteStamped reference-health badge
22/22 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 22 checked references that resolve
resolves10.1093/rheumatology/keab223
COVID-19 vaccination and antirheumatic therapy
resolves10.1093/ndt/gfab064
Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases
resolves10.1038/s41586-020-2521-4
Factors associated with COVID-19-related death using OpenSAFELY
resolves10.1016/j.kint.2020.10.032
Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring
resolves10.1056/NEJMoa2034577
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
resolves10.1016/S0140-6736(21)00432-3
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
resolves10.1056/NEJMoa2035389
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
resolves10.1016/S0140-6736(21)00234-8
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
resolves10.1136/ard.2007.077461
Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response
resolves10.1002/acr.22246
Effect of Methotrexate, Anti–Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis
resolves10.1016/j.vaccine.2010.12.072
The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab
resolves10.1002/art.25033
Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
resolves10.1016/S0140-6736(21)00502-X
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
resolves10.1016/j.ekir.2021.02.006
Serologic Screening for Coronavirus Disease 2019 in Patients With Glomerular Disease
resolves10.2807/1560-7917.ES.2021.26.6.2100096
Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021
resolves10.1002/art.41734
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1
resolves10.1136/rmdopen-2021-001594
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases
resolves10.1038/s41586-020-03041-6
Correlates of protection against SARS-CoV-2 in rhesus macaques
resolves10.1016/j.jaci.2020.04.013
A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia
resolves10.1111/pai.13263
Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover
resolves10.1016/j.jinf.2021.05.024
Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies
resolves10.1016/S0140-6736(20)31604-4
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
The 4 references without a DOI — listed, not checked
no DOI — not checked10.1136/annrheumdis-2021-220626_bib3
no DOI — not checkedRisk factors for severe outcomes in patients with systemic vasculitis & COVID-19: a bi-national registry-based cohort study
no DOI — not checked10.1136/annrheumdis-2021-220626_bib19
no DOI — not checkedBNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1136/annrheumdis-2021-220626"><img src="https://citestamp.com/citestamped/10.1136/annrheumdis-2021-220626/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1136/annrheumdis-2021-220626/badge.svg)](https://citestamp.com/citestamped/10.1136/annrheumdis-2021-220626)